Avalyn Pharma, Inc. (AVLN)
26.04
-1.21
(-4.44%)
USD |
NASDAQ |
Oct 23, 16:00
26.04
0.00 (0.00%)
After-Hours: 20:00
Avalyn Pharma Net Income (Quarterly) : -28.94M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -28.94M |
| March 31, 2026 | -26.87M |
| Date | Value |
|---|---|
| June 30, 2025 | -20.19M |
| March 31, 2025 | -17.50M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | -8.603M |
| CorMedix, Inc. | 25.99M |
| Eloxx Pharmaceuticals, Inc. | -4.502M |
| Breakthrough Chemistry, Inc. | -1.083M |
| BioStem Technologies, Inc. | -8.971M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 28.94M |
| EPS Diluted (Quarterly) | -0.6527 |
| Enterprise Value | 872.76M |
| Earnings Yield | -8.10% |
| Normalized Earnings Yield | -8.099 |